CF Patients with 2 F508del Mutations to Test Vertex's VX-659 Combo in Phase 3 Trial

CF Patients with 2 F508del Mutations to Test Vertex's VX-659 Combo in Phase 3 Trial

Vertex’s VX-659 Triple Combo To Be Tested in Phase 3 Trial in Patients with 2 Copies of F508del Mutation

MARCH 2, 2018

BY ALICE MELÃO

 

IN CYSTIC FIBROSIS, NEWS.